A Sardinian patient with ankylosing spondylitis and HLA-B*2709 co-occurring with HLA-B*1403

Arthritis and Rheumatism

Volumn 56, Issue 8, 2007, Pages 2807-2809

  Cauli, Alberto ^a   Vacca, Alessandra ^a   Mameli, Antonella ^a   Passiu, Giuseppe ^a   Fiorillo, Maria Teresa ^b   Sorrentino, Rosa ^b   Mathieu, Alessandro ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B ANTIGEN;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HLA SYSTEM; HUMAN; ITALY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SACROILIAC JOINT;

ADULT; ALLELES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HISTOCOMPATIBILITY TESTING; HLA-B ANTIGENS; HUMANS; SACROILIAC JOINT; SPONDYLITIS, ANKYLOSING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34547725596     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.22819     Document Type: Article

References (11)

1. D'Amato M, Fiorillo MT, Carcassi C, Mathieu A, Zuccarelli A, Bitti PP, et al. Relevance of residue 116 of HLA-B27 in determining susceptibility to ankylosing spondylitis. Eur J Immunol 1995;25:3199-201.
2. Paladini F, Taccari E, Fiorillo MT, Cauli A, Passiu G, Mathieu A, et al. Distribution of HLA-B27 subtypes in Sardinia and continental Italy and their association with spondylarthropathies. Arthritis Rheum 2005;52:3319-21.
3. Olivieri I, Ciancio G, Padula A, Gaudiano C, Masciandaro S, Moro L, et al. The HLA-B*2709 subtype confers susceptibility to spondylarthropathy. Arthritis Rheum 2002;46:553-4.
4. Hulsmeyer M, Fiorillo MT, Bettosini F, Sorrentino R, Saenger W, Ziegler A, et al. Dual, HLA-B27 subtype-dependent conformation of a self-peptide. J Exp Med 2004;199:271-81.
5. Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8.
6. Lopez-Larrea C, Mijiyawa M, Gonzalez S, Fernandez-Morera JL, Blanco-Gelaz MA, Martinez-Borra J, et al. Association of ankylosing spondylitis with HLA-B*1403 in a West African population. Arthritis Rheum 2002;46:2968-71.
7. Merino E, Montserrat V, Paradela A, Lopez de Castro JA. Two HLA-B14 subtypes (B*1402 and B*1403) differentially associated with ankylosing spondylitis differ substantially in peptide specific-ity but have limited peptide and T-cell epitope sharing with HLA-B27. J Biol Chem 2005;280:35868-80.
8. Sudarsono D, Hadi S, Mardjuadi A, Nasution AR, Dekker-Saeys AJ, Breur-Vriesendorp BS, et al. Evidence that HLA-B*2706 is not protective against spondyloarthropathy. J Rheumatol 1999;26:1934-6.
9. Mathieu A, Sorrentino R. HLA-B*2709 and spondylarthropathies: comment on the concise communication by Olivieri et al [letter]. Arthritis Rheum 2003;48:866-7.
10. Fiorillo MT, Cauli A, Carcassi C, Bitti PP, Vacca A, Passiu G, et al. Two distinctive HLA haplotypes harbor the B27 alleles negatively or positively associated with ankylosing spondylitis in Sardinia: implications for disease pathogenesis. Arthritis Rheum 2003;48:1385-9.
11. Brown MA, Kennedy LG, Darke C, Gibson K, Pile KD, Shatford JL, et al. The effect of HLA-DR genes on susceptibility to and severity of ankylosing spondylitis. Arthritis Rheum 1998;41:460-5.